#immunotherapy
4 stories
Oncolytics Biotech Secures Patent Extensions
Oncolytics Biotech extends cancer immunotherapy patent protection to late 2040s with new intellectual property updates.
Financialpost · 1m

Eddingpharm's GB268 Trial Approved in China
China's NMPA clears Eddingpharm's GB268 Phase 2 colorectal cancer trial.
BigGo Finance · 1m

Cancer deaths fall, but young people face rising risk
U.S. cancer mortality is declining thanks to medical breakthroughs, but early-onset diagnoses among adults under 50 are climbing, especially in women.
PhillyVoice · 2m

OpenAI's $40M bet on cancer vaccines
A North Carolina cancer center just got $40 million to build the biological data AI needs to design better tumor vaccines.
ABC7 Los Angeles · 1m